CompletedNot Applicable

The Role of ICSI in Non-male Factor Infertility in Advanced Maternal Age

Israel69 participantsStarted 2018-01-01

Plain-language summary

The use of Intracytoplasmic sperm injection (ICSI) has increased in the last decades regardless of the cause of infertility. Despite the increased use there is no clear evidence that ICIS is more effective than conventional in vitro fertilization (IVF) for non-male factor infertility. The investigators therefore aim to perform a prospective randomized controlled study to compare between ICSI and conventional IVF in women between 39 to 44 years of age with non-male factor infertility.

Who can participate

Age range39 Years – 44 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women between 39 to 44 years of age undergoing IVF treatments for non-male factor infertility. Exclusion Criteria: * Women undergoing IVF treatments for male factor infertility. * Cases where PGD is planned. * Women with a BMI above 40. * Women younger then 39 years of age or older then 44 years of age. * Women with a rate of fertilization bellow 50% in previous IVF cycles.

What they're measuring

Fertilization rate

Timeframe: 1 day

Trial details

NCT IDNCT03370068

SponsorDr. Tal Miller-Elkan

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-07-01

View on ClinicalTrials.gov More Infertility, Female trials